GC Genome Stock

GC Genome EBITDA per Employee

The EBITDA per Employee of GC Genome (340450.KQ) as of Aug 15, 2026 is 9.88 M KRW. In the previous year, EBITDA per Employee was -6.98 M KRW — a change of -241.68% (higher).

EBITDA per Employee

9.88 MKRW

YoY

-241.68%

Last updated:

EBITDA per Employee of GC Genome is 2026 9.88 M KRW. EBITDA per Employee of GC Genome was 2025 -6.98 M KRW. It decreases by -241.68% higher compared to the previous year.
Access this data via the Eulerpool API
Get Free API Key

GC Genome Stock analysis

What does GC Genome do? GC Genome is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GC Genome stock

EBITDA per Employee of GC Genome is 9.88 M KRW in 2026.

EBITDA per Employee of GC Genome changed from -6.98 M KRW to 9.88 M KRW, representing a -241.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Employee GC Genome since 2006 – with annual values, charts, and detailed analysis.

EBITDA per employee measures operating cash earnings generated per employee, showing workforce productivity before depreciation and financing effects.

EBITDA per Employee's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA per Employee's GC Genome historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Workforce — GC Genome

EmployeesRevenue per EmployeeProfit per EmployeeMarket Cap per EmployeeEBIT per EmployeeEBITDA per EmployeeR&D per EmployeePP&E per Employee

All Key Metrics — GC Genome